← European Medicine Shortage Tracker · all medicines

Abiraterona shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Abiraterona currently has availability issues reported in 4 European registers: Austria, Germany, Spain, Sweden.

Shortage  ATC L02BX03 · also listed as: ABIRATERONACETAT · ABIRATERONA · data refreshed 10 September 2026

Key facts

As of 10 September 2026, 4 of the 9 tracked registers list current availability issues for Abiraterona, covering 6 affected product presentations. The longest-running open report was filed in Sweden on 2023-02-22 and has now been open for about 43 months. Where agencies state a cause, unexpectedly high demand lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-09-18. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Sweden reported first (2023-02-22), with Austria following roughly 41 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Spain, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Abiraterona is coded L02BX03 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇦🇹 AustriaShortage
Abirateron 1A Pharma 1000 mg – Filmtabletten
+ 1 more products
Abirateron Sandoz 1000 mg – Filmtabletten
2026-07-08register ↗
🇩🇪 GermanyShortage
Abirateron HEXAL 1000 mg Filmtabletten
+ 1 more products
Abirateron HEXAL 500 mg Filmtabletten
2026-01-212026-10-16Erhöhte Nachfrage
Alternatives: N/A
register ↗
🇪🇸 SpainShortage
ABIRATERONA TEVA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos
2023-08-23Existen otros medicamentos con el mismo principio activo y misma vía.
Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.
register ↗
🇸🇪 SwedenShortage
Abirateron Avansor 500 mg Filmdragerad tablett
2023-02-222026-12-31
Alternatives: Alternative(s) available — see the national register.
register ↗

New register reports per month

2026-01: 12026-02: 12026-03: 02026-04: 02026-05: 02026-06: 02026-07: 22026-012026-07

Full report history (6 register entries)

Every individual register entry for Abiraterona in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇦🇹 ATAbirateron 1A Pharma 1000 mg – FilmtablettenShortage2026-07-30
🇦🇹 ATAbirateron Sandoz 1000 mg – FilmtablettenShortage2026-07-08
🇩🇪 DEAbirateron HEXAL 500 mg FilmtablettenShortage2026-02-112026-09-18Sonstige
🇩🇪 DEAbirateron HEXAL 1000 mg FilmtablettenShortage2026-01-212026-10-16Erhöhte Nachfrage
🇪🇸 ESABIRATERONA TEVA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 cShortage2023-08-23Existen otros medicamentos con el mismo principio activo y m
🇸🇪 SEAbirateron Avansor 500 mg Filmdragerad tablettShortage2023-02-222026-12-31

Frequently asked

Is Abiraterona currently in shortage in Europe?

Yes. As of 10 September 2026, availability issues are reported in: Austria, Germany, Spain, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Abiraterona shortage expected to end?

Agency prognoses on file range from 2026-09-18 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Abiraterona?

4 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Abiraterona availability data come from?

Directly from the official medicines-agency registers that list Abiraterona: BASG (Austria), BfArM (Germany), AEMPS CIMA (Spain), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Abiraterona — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/abiraterona/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Abiraterona availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/abiraterona/">Abiraterona shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Abiraterona: availability status across 4 European registers — European Medicine Shortage Tracker (MobiDoctor), 10 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.